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Title: Effect of Intravenous Ondansetron on Blood Pressure when Administered Prior 
to the Establishment of Subarachnoid Anesthesia. 
 
Background: Hypotension is a known effect of spinal anesthesia. In recent years, ondansetron 
has been explored as another means of attenuating spinal-anesthesia induced hypotension (SIH).  
 
Purpose: This case study looks at one clinical application of this intervention and examines the 
literature on the topic to determine the usefulness of administering IV ondansetron prior to spinal 
anesthesia.  
 
Process: In the clinical setting, IV ondansetron was given prior to administering spinal 
anesthesia; this case is discussed in detail. The databases CINAHL and PubMed were searched 
to attain 13 randomized controlled trials which studied this intervention. These studies were 
reviewed and recommendations were made based on the literature.  
 
Results: More uniform research should be done on this topic. However, it can be recommended 
to administer 4 mg ondansetron intravenously about 5 minutes before establishing spinal 
anesthesia. Existing methods of preventing and treating SIH should still be employed when 
necessary.   
 
Implications: IV ondansetron can be used as an additional tool to help prevent spinal-induced 
hypotension, potentially minimizing adverse outcomes associated with hypotension resulting 
from spinal anesthesia.  
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Background 
Spinal anesthesia is the administration of local anesthetic agents, and other adjunct 
medications into the subarachnoid space with the purpose of blocking sensory and motor 
transmission at the roots of spinal nerves. It was first successfully used in 1898 on a patient 
having surgical resection of a tuberculous ankle joint who had previous adverse reactions to 
general anesthesia. Fifteen milligrams (mg) of cocaine was administered intrathecally. The 
patient was pain free during surgery and had minimal adverse effects post-operatively including 
nausea and headache (Wulf, 1998). Today, spinal anesthesia is commonly used for various 
procedures involving the lower extremities, perineum, and abdomen (Nagelhout, 2014).  
Hypotension is a known side-effect of spinal anesthesia. Tubog, Kane, and Pugh (2017), 
cite the incidence of spinal anesthesia-induced hypotension (SIH) at 15-33%. Some sources 
indicate an even higher (as high as 80%) prevalence (Wang et al., 2014). The variable prevalence 
rate can be owed to individual patient factors, including comorbidities and anesthetic technique. 
Many sources indicate that the incidence of hypotension is greater in the obstetric population 
than in other patient populations. Hypotension has negative implications on every population as 
it can result in decreased perfusion and oxygen delivery to vital organs. Further implications 
exist in the obstetric population, “hypotension during spinal anesthesia for cesarean delivery 
remains a common clinical problem that is associated with morbidity for both mother (nausea 
and vomiting) and fetus (fetal acidosis)” (Ngan Kee, Khaw, & Ng, 2005, p. 744).   
Often, the current preventative treatments are not sufficient, requiring pharmacological 
intervention which becomes a reactive strategy rather than proactive. Recently, a new measure, 
the administration of intravenous ondansetron prior to administering the spinal anesthetic, has 
come into question as a viable preventive strategy to mitigate SIH. If this proves to be true, it 
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could improve the safety of spinal anesthesia by decreasing the incidence of hypotension and its 
negative effects.  
Case Report 
 A 64-year-old, 5’2”, 72.5 kg female, presented for a total knee arthroplasty. She had 
osteoarthritis of both knees requiring replacement, however, only the left knee was to be 
replaced. Her past medical history included asthma, GERD, and hypertension. She had a past 
surgical history of rotator cuff repair, tubal ligation, and knee arthroscopy. Her home 
medications included albuterol, Celebrex 200 mg, gabapentin 100 mg, hydrochlorothiazide 25 
mg, and omeprazole 20 mg. She had no known drug allergies and was classified as an ASA 2. 
Pre-anesthetic evaluation did not reveal any abnormal labs or studies. Physically, she presented 
with knee pain. Her airway evaluation was unremarkable. Baseline vital signs were as follows: 
BP 138/84, HR 74, RR 16, SpO2 95%, and temperature 98.9 degrees Fahrenheit. In the 
preoperative holding room, an 18-gauge IV was started in her left hand and she was given 2 mg 
midazolam.  
 The patient was brought to the OR at 0631, was given 4 mg ondansetron intravenously, 
and was given a bolus of 500 mL lactated ringers, while being attached to standard monitoring. 
Initial BP while supine was 135/85 (101) with a HR of 79. Additionally, 6 mg of midazolam 
(now a total of 8 mg) was administered prior to the block per the anesthesiologist’s request. She 
was positioned in a sitting position on the OR table and a spinal block was administered at 0645. 
The following medications were administered intrathecally: 1.6 ml of bupivacaine 0.75% (12 
mg) and 25 mcg of fentanyl. After the block, she was immediately placed in a supine position 
and a propofol infusion was started at a rate of 12.5 mcg/kg/min. Oxygen was also applied via 
nasal cannula at three liters per minute. Additionally, one gram of Ancef and one gram of 
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tranexamic acid were administered during this time. The first BP after the block was established 
was 109/68 (88). Ten minutes after the block was established the BP dropped to 101/60 (73) and 
100 mcg of phenylephrine was administered. This was the only dose of vasopressor given. The 
tourniquet was inflated at 0708 and incision was made 0710. Systolic blood pressures after the 
block ranged from 98 to 120, and diastolic blood pressures ranged from 53-68. The lowest MAP 
that was encountered was 68 and occurred 85 minutes after the block was administered. Heart 
rate throughout the case ranged from 58-80 BPM.  The tourniquet was let down at 0801 and a 
second gram of tranexamic acid was given. The propofol infusion was discontinued at 0813. A 
total of 1,200 mL LR was given throughout the case and 225 mL was determined to be the 
estimated blood loss. The patient was transferred to the PACU at 0831 with the following vital 
signs: BP 108/64, HR 61, SpO2 100%, RR 14. It was realized that the surgeon forgot to apply 
the subcutaneous layer of sutures and he decided to do this at the bedside in the PACU. To 
facilitate this, two additional mg of midazolam were administered.  
Discussion 
Spinal Anesthesia 
 Spinal anesthesia is the injection of medications into the subarachnoid space, which 
contains cerebrospinal fluid, with the purpose of blunting or abolishing sensory and/or motor 
nerve transmission (Nagelhout & Plaus, 2014). It’s advantages over general anesthesia include 
less nausea and vomiting, less urinary retention, reduced opioid requirement, greater mental 
awareness, less intraoperative blood loss, decreased incidence of thrombotic events, and less risk 
of developing a post-op ileus. Additionally, patients have improved respiratory and cardiac 
stability, and are quicker to drink, eat, and ambulate post-operatively (Nagelhout & Plaus, 2014).  
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Indicated procedures for the use of spinal anesthesia include those involving the lower 
extremities, perineum, and abdomen. It is especially useful for ambulatory procedures as many 
complications of general anesthesia are avoided, greatly decreasing the possibility for unforeseen 
overnight hospital stays. Spinal anesthesia is very useful in obstetric procedures as it provides 
adequate pain control while still allowing baby and mother interaction post-delivery. 
Additionally, patients undergoing urologic procedures, such as TURP, can benefit from a spinal 
anesthetic as they can alert the urologist of feelings of bladder overdistention, thus reducing the 
risk of rupture. Maintaining alertness in these patients also has benefit in that it allows the 
anesthetist to detect changes in mental status which is often the first sign of TURP syndrome 
(Nagelhout, 2014).  
There are some contraindications to spinal anesthesia. Absolute contraindications include 
patient refusal, infection at the injection site, symptomatic hypovolemia, coagulopathy, 
indeterminate neurological disease, and increased intracranial pressure (NYSORA, 2017). 
Patients with a fixed volume cardiac state (such as hypertrophic cardiomyopathy or severe atrial 
stenosis) or with severe aortic stenosis (valve area < 1.0 cm2) will not tolerate bradycardia and 
hypotension as it will lead to coronary hypoperfusion (Nagelhout, 2014).  Relative 
contraindications are infection elsewhere, not at the injection site, unknown duration of surgery, 
sepsis, uncooperative patient, preexisting neurological deficits, demyelinating lesions, and spinal 
deformity (Butterworth, Mackey, & Wasnick, 2013).  
There are side effects to spinal anesthesia as well. The severity of these are often 
dependent on the level of the block. Cardiovascular side effects can include hypotension, and 
bradycardia. Vasomotor tone is influenced by autonomic efferent fibers arising from T5 – L1 
spinal levels. Cardiac accelerator nerve fibers exist at spinal levels T1-T4. Pulmonary side 
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effects are rare, but the phrenic nerve can be impacted if the block rises to cervical nerves 3 – 5, 
causing decreased diaphragm function (Butterworth, Mackey, & Wasnick 2013). Nausea and 
vomiting can occur in up to 20% of patients who receive neuraxial anesthesia. This is primarily a 
result of hypotension and decreased perfusion to the medulla of the brain, but can also be a result 
of increased GI peristalsis due to dominance of parasympathetic input. Finally, with spinal 
anesthesia, there is risk of dural puncture and CSF leak, resulting in what is referred to as a 
postdural puncture headache. This occurs as the brain loses its “cushion” which is provided by 
circulating CSF. The risk of this side effect can be minimized by using smaller gauge, pencil 
point needles (Nagelhout & Plaus, 2014).  
Mechanism of Spinal Anesthesia-Induced Hypotension 
When local anesthetic agents are introduced into the subarachnoid space, the drug 
spreads from the injection site and its concentration gradient decreases as it moves further from 
this area. A differential blockade results as only the most “local anesthetic susceptible” neurons 
will be blocked in the areas of this decreased concentration gradient. Type B autonomic nerve 
fibers (sympathetic fibers) are of the most susceptible neurons as they are relatively small in 
diameter and lightly myelinated. Because of this, sympathetic neurons tend to be blocked up to 
six spinal segments above somatic sensory fibers, which are generally larger in diameter and 
more heavily myelinated (Nagelhout & Plaus, 2014).  
Nagelhout & Plaus (2014) describe the cardiovascular effects of spinal anesthesia, 
“Blockade of the sympathetic nervous system causes arterial vasodilation, decreased systemic 
vascular resistance, venous pooling, and reduction in venous return. These changes cause a 
redistribution of blood that often results in hypotension” (p. 1083). If the block reaches the 
cardiac accelerator fibers, at levels T1 to T4, this hypotension can be amplified by the 
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development of bradycardia and decreased cardiac output. In addition to the decreased 
sympathetic outflow, the cardiovascular response to spinal anesthesia is affected by baroreceptor 
reflexes, volume receptor reflexes, and the Bezold-Jarisch reflex (Nagelhout & Plaus, 2014).  
The Bezold-Jarisch reflex (BJR) “is a cardioinhibitory reflex producing bradycardia, 
hypotension, and cardiovascular collapse via nonmyelinated, type C fibers whose terminals lie in 
the chambers of the heart” (Tubog, Kane, & Pugh, 2017). Trebelsi et al. (2017) indicate that 5-
hydroxytriptymine subtype 3 (5-HT3) receptors located peripherally may aid in inducing the 
BJR. Terkawi et al., 2015 further explain this, “This reflex is mediated by serotonin receptors (5-
HT3 subtype) located on the vagus nerve and within the wall of cardiac ventricles. They are 
activated by serotonin release in response to systemic hypotension and cause an increase in 
efferent vagal signaling” (p.344).  
Detrimental Effects of Spinal-Induced Hypotension  
 Perfusion to vital organs depends on adequate blood pressure. Hypotension decreases 
perfusion and oxygen delivery which, if severe, will cause ischemia and tissue death. Ortiz-
Gomez et al. (2014) outlines the detriments of hypotension in the parturient, including “maternal 
nausea and vomiting, and in severe cases unconsciousness, pulmonary aspiration, and placental 
hypoperfusion with fetal hypoxia, acidosis, and neurologic injury” (p. 138). Wang et al. (2014) 
adds neonatal apnea to this list of hypotension related complications.  
In non-obstetric populations, patients may more frequently have comorbidities, such as 
hypertension or vascular disease, which might place them at risk for cerebral or myocardial 
ischemia related to dramatic decreases in blood pressure. Hines and Marschall (2012) state, 
“Chronic hypertension is a cardiovascular, cerebrovascular, and renal risk factor” (p.111-112). 
They elaborate by citing intraoperative hypotension as a complicating factor in these patients 
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(Hines & Marschall, 2012, p.112). Furthermore, interventions to correct hypotension, such as 
volume replacement or administration of ephedrine, might be risky in elderly patients with heart 
failure or history of myocardial ischemia (Owczuk et al., 2017). Volume overload can exacerbate 
heart failure, and ephedrine can increase myocardia oxygen demand via tachycardia. 
Compromised coronary circulation may not have the ability to increase oxygen supply to meet 
this demand, which could result in the development of ischemia (Hines & Marschall, 2013, p.1).  
Traditional Treatments for SIH  
 Common preventative and treatment measures for SIH have included positioning, lower 
leg compression, loading and co-loading of crystalloids, and administration of alpha and beta-
adrenergic agonists (Tubog, Kane, & Pugh, 2017). Positioning in trendelenburg can help to 
increase venous return, as will lower leg compression, however a large reservoir for volume is in 
the splanchnic and GI circulation which leg compression is unable to aid in correcting. Pre-
loading of crystalloids has not proven effective as much of the volume third spaces prior to the 
administration of the block. In addition, patients with cardiac or renal deficits, may not tolerate 
the volumes used for pre-loading (10-20 ml/kg). Vasopressors are reactive treatments to 
hypotension that develops from subarachnoid anesthesia, and while effective, may possess some 
negative effects. Pure alpha-adrenergic agonists, such as phenylephrine, might exacerbate 
bradycardia that may be brought on by the SAB, and though mixed alpha- and beta-adrenergic 
agonists (ephedrine) can be effective, some patients may not tolerate the increase in HR that 
accompanies their administration (Butterworth, Mackey, & Wasnick, 2013). Other limitations to 
ephedrine can include a relatively slow onset of action and the development of tachyphylaxis 
(Lee, George, & Habib, 2016). There is clearly no definitive treatment for SIH, which makes 
new options to prevent this side effect appealing to explore.  
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Serotonin 
 Serotonin (5-hydroxytriptymine [5-HT]) is a neurotransmitter which exerts its effects in 
many ways throughout the body by binding to a variety of receptors. Principally, in the 
cardiovascular system, serotonin induces vasoconstriction (Brunton, Hilal-Dandan, & 
Knollmann, 2018). Terkawi et al., (2015) describe this as a result of it binding to 5-HT2 
receptors. In the heart, serotonin is both a positive inotrope and positive chronotrope as it binds 
to various different 5-HT receptors (Brunton, Hilal-Dandan, & Knollman, 2018). However, when 
it binds to 5-HT3 receptors it will activate the BJR causing bradycardia and hypotension 
(Terkawi et al, 2015).  
 The gastrointestinal tract is the primary site of synthesis and storage of serotonin. 
Different subtypes of serotonin receptors are responsible for both activation and suppression of 
intestinal smooth muscle action, enhancing or suppressing GI motility. Serotonin which acts on 
5-HT3 receptors in the GI tract and in the central nervous system induces the emetic response, 
causing nausea and vomiting (Brunton, Hilal-Dandan, & Knollman, 2018).  
 The brain contains all serotonin receptor subtypes. Serotonin is active in the brain in 
many ways and influences sleep, cognition, sensory perception, motor activity, temperature 
regulation, nociception, mood, appetite, sexual behavior, and hormone secretion. Other various 
effects of serotonin include that in the inflammatory response as it is pro-inflammatory via 5-
HT2 receptors and may play a role in airway inflammation in diseases such as asthma. 
Additionally, serotonin is released from platelets to cause a local vasoconstrictor response, 
promoting hemostasis after vessel damage (Brunton, Hilal-Dandan, & Knollman, 2018).  
 
 
IV ONDANSETRON PRIOR TO SPINAL ANESTHESIA  12 
 
Ondansetron  
 Ondansetron is a serotonin receptor subtype 3 (5-HT3) antagonist. It is commonly used as 
an antiemetic, working to block 5-HT3 receptors in the GI system and in the chemoreceptor 
trigger zone of the brain. It has a rapid onset and its duration of action is about 6-12 hours (Vargo 
Anesthesia, 2012). Aside from its central action in the brain, ondansetron will bind to 5-HT3 
receptors peripherally, including those within the cardiac ventricles and on the vagus nerve, 
which help to mediate the BJR (Trebelsi et al., 2017). Binding these receptors prevents induction 
of the BJR and decreases parasympathetic dominance, lessening the degree of bradycardia and 
hypotension brought about by spinal anesthesia.  
 Adverse Effects  
 The most common adverse effects of ondansetron (and other 5-HT3 antagonists) include 
diarrhea, fever, and headache (Butterworth, Mackey, & Wasnick, 2013). Wang et al. (2014), also 
cite constipation and asthenia as potential side effects. There have also been reports of 
prolongation of the QT interval with these agents (more frequently with Dolasetron), however, 
this effect has not been linked clinically to any adverse arrhythmias. It may also be important to 
note that ondansetron is metabolized by the CYP-450 enzymes of the liver, necessitating 
consideration in its dosing for patients in liver failure (Butterworth, Mackey, & Wasnick, 2013). 
Finally, in previous years, there has been concern that prenatal exposure to ondansetron can 
cause adverse outcomes of pregnancy including spontaneous abortion, still birth, major birth 
defects, preterm delivery, and low birth weight infants. Wang et al. (2014), explain that 
appropriate exposure to ondansetron does not cause these adverse effects. “Ondansetron 
administration during the first trimester of pregnancy is not associated with an increased risk for 
major malformations above baseline” (Wang et al, 2014, p.5214).  
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Ondansetron Administered Prior to SAB 
 A total of 13 randomized controlled trials, which explored the effects of intravenous 
ondansetron administered prior to the establishment of spinal anesthesia, were reviewed. 
Methods of each trial are similar although there is some variability.  
 Obstetric Populations 
 Trabelsi et al. (2015) examined the effect ondansetron has on maternal hypotension and 
on certain neonatal parameters, including APGAR score, umbilical artery pH, and neonatal 
lactate levels. They included 80 patients undergoing cesarean section split into two groups, a 
control group and an intervention group which received 4 mg ondansetron five minutes prior to 
SAB. Saline (10 ml/kg) was given as a bolus as well.  The spinals included 2 ml bupivacaine 
0.5% (10 mg) and 10 mcg sufentanil. Hypotension was defined as a drop in BP > 20% from 
baseline, or MAP < 80 mmHg. They determined that a statistically significant difference existed 
in the incidence of hypotension (77.5% in the control group, 37.5% in the group which received 
ondansetron) between groups. They also note that more ephedrine was required in the control 
group. Of the neonatal parameters, they found higher APGAR scores, lower lactate levels, and 
higher cord arterial pH in the intervention group (p. 1-7).  
  Wang et al. (2014) looked at different doses of ondansetron compared to a control group 
and how it affected hemodynamics in parturient patients undergoing cesarean section. They also 
looked at neonatal outcomes. One hundred and fifty primiparous patients were split into five 
equal groups; a control group, and four intervention groups each of which received either 2, 4, 6, 
or 8 mg of ondansetron 5 minutes prior to establishment of the SAB. All patients were injected 
with 10 mg bupivacaine intrathecally. After the spinal was performed, LR solution was given 
rapidly up to 10 ml/kg. After delivery, 10 units oxytocin in 250 ml saline was given at an 
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unspecified rate. Hypotension was defined as a drop in baseline SBP by 20% or greater. The 
incidence of hypotension was found to be less in the groups who received ondansetron in 4 mg 
and 6 mg doses, and these differences were found to be statistically significant. Regarding 
neonatal outcomes, no significant differences were noted in APGAR scores, birth weight, nor 
umbilical cord arterial pH between groups. The pH of umbilical cord venous blood, however, 
was significantly higher in the group which received four mg ondansetron (p. 5210-5216).  
 Terkawi et al. (2015) had differing results in their study which evaluated ondansetron’s 
effect on hemodynamics in patients undergoing cesarean section. Eighty-six patients were split 
into two groups, a control group and an intervention group which received 8 mg ondansetron five 
minutes prior to SAB. All patients were preloaded with 500 ml Hetastarch, and plasmalyte was 
used as maintenance fluid. The spinal was established using 2 mL of 0.75% bupivacaine (15 
mg), with 20 mcg fentanyl, and 100 mcg morphine. Hypotension was defined as SBP < 90 
mmHg. They determined there was no significant difference in the development of hypotension 
between the two groups. They also did not find a difference in amount of vasopressor used to 
correct hypotension (p. 344-348).  
 Khouly & Meligy (2016) looked at 102 parturients undergoing cesarean section. A 
control group which received saline was compared to the intervention group which received 4 
mg ondansetron five minutes prior to SAB. Two mL of 0.5% bupivacaine (10 mg) was 
administered intrathecally to each patient. After the spinals were administered, patients were 
placed supine with a left tilt. Hypotension was defined as SBP < 75% baseline value, SBP below 
90 mmHg, or DBP < 60 mmHg. The authors determined that SBP, MAP, and HR values were 
increased in the intervention group compared to the control group. Additionally, less 
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vasopressors were required in the intervention group; ephedrine was administered to 58% of 
patients in the control group versus 30% of patients in the intervention group (p. 205-209).  
 Sahoo, SenDasgupta, Goswami, & Harza (2012) looked at parturient patients undergoing 
cesarean section as well, using a control group (n = 26) and an intervention group (n = 26) which 
received 4 mg ondansetron prior to the SAB. All patients were pre-loaded with lactated ringers 
20 ml/kg/h over 30 minutes. The spinal was established using 2 mL 0.5% bupivacaine (10 mg) 
and a left tilt was applied post-block. Hypotension was defined as SBP < 90 mmHg or DBP < 60 
mmHg. Significant MAP decreases were observed in both groups. In the intervention group, the 
lowest average mean arterial pressure was 82 mmHg compared to 74 mmHg in the control 
group. Additionally, 42% of control group patients required phenylephrine administration versus 
7.6% of intervention group patients. (p. 24-28).  
 Ortiz-Gomez et al. (2014) examined 128 parturients who underwent cesarean section. 
The subjects were divided into four equal groups; a control group, and three study groups which 
received different doses of ondansetron (2 mg, 4 mg, & 8 mg) prior to SAB. The dose of 
hyperbaric bupivacaine 0.5% was administered based on height (height in cm X 0.06), and 20 
mcg fentanyl was added to each. The authors found no significant difference in the incidence of 
hypotension. They did, however, find that the study groups which received 4 mg and 8 mg of 
ondansetron required about half as much ephedrine to correct hypotension (p. 138-143).  
 Marciniak et al. (2015) studied 72 patients undergoing cesarean section. The study cohort 
was split into two groups, a control group and an intervention group in which each patient 
received 8 mg ondansetron five minutes before administration of the spinal. Each patient was 
preloaded with Hetastarch 10 ml/kg. Bupivacaine 0.5% was administered according to height 
(1.8-2.2 ml; 9-11mg). Fentanyl 15 mcg was added to each spinal preparation. Post-block, every 
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patient was positioned supine with a left tilt. Hypotension was defined as a 20% decrease in SBP 
or SBP < 90 mmHg. The authors determined that were no significant differences in 
hemodynamic parameters between each group (p. 461-467).  
 Karacaer et al. (2017) examined prophylactic intravenous ondansetron and its effect on 
norepinephrine consumption in patients undergoing cesarean section. A total of 108 patients 
were split evenly into a control group and an intervention group, which received 8 mg 
ondansetron intravenously prior to receiving the spinal. Co-loading with LR was done, and each 
patient was administered 10 mg bupivacaine, and 20 mcg fentanyl intrathecally. After the spinal 
administration, all patients were placed supine with a left tilt. Hypotension was defined as SBP < 
80% of the patient’s baseline value. The authors determined that incidence of hypotension was 
statistically equal between groups (88% versus 87%), however, norepinephrine consumption was 
greater in the control group. In this group, 35.7 +/- 25.8 mcg of norepinephrine was required, 
versus the intervention group where 22.6 +/- 19.5 mcg of norepinephrine was used (90-97). 
 A study by Nivatpumin & Thamvittayakul (2016) compared the effectiveness of 
ondansetron and ephedrine using the respective intervention groups (ondansetron 8 mg, 
ephedrine 10 mg), as well as a control group. One hundred and sixty-eight patients were 
enrolled. Each patient was pre-loaded with 500 ml LR, and a spinal was delivered with 11 mg 
bupivacaine and 200 mcg morphine. The study medications (ephedrine or ondansetron) were 
given after administration of the spinal. Each patient was also placed supine with left tilt at this 
time. Hypotension was defined as SBP < 90 or SBP decrease of 20% or greater. The authors 
determined that “the proportions requiring ephedrine and/or norepinephrine after spinal 
anesthesia in group [ephedrine] and [ondansetron] were not significantly different” (p. 27) and 
that the incidence of hypotension was not significantly different between groups (25-31).  
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 Wang et al. (2014) looked at the effectiveness of ondansetron preloading coupled with 
crystalloid infusion to reduce maternal hypotension after spinal anesthesia for cesarean sections. 
A control group was compared with an intervention group which received 4 mg ondansetron 
prior to the delivery of the spinal anesthetic. All patients were given 2 mL of 0.5% (10 mg) 
bupivacaine and were bolused with 10 mL/kg Lactated Ringer’s solution. Hypotension was 
defined as SBP < 80% baseline and was treated with phenylephrine. The study showed a mean 
maximal decline in SBP of 18.9 +/- 6.3 mmHg in the group which received ondansetron and 30.7 
+/- 16.6 mmHg in the control group. This was determined to be statistically significant. 
Phenylephrine administration was also significantly different with the intervention group 
receiving a total of 1,300 mcg and the control group receiving 3,100 mcg in total (p. 913-922).  
 Non-Obstetric Populations 
 Marashi, Soltani-Omid, Mohammadi, Aghajani, & Movafegh (2014) completed a study 
that compared administration of ondansetron in two doses (6 mg and 12 mg) to a placebo dose of 
saline. Two hundred and ten patients in varying procedures (urologic, orthopedic, and 
gynecological) were divided into three groups; a control group which received saline, a group 
which received ondansetron 6 mg, and a group which received ondansetron 12 mg prior to 
administering the SAB. Hyperbaric 0.5% bupivacaine 15 mg was used for the block. They 
defined hypotension as a MAP < 80 mmHg and their findings illustrate that only patients in the 
control group (17%) developed hypotension. This was determined to be of statistical 
significance. The authors did not indicate how each patient population was distributed to each 
study group (p.1-5). 
Owczuk et al. (2008) compared 35 patients in a control group to 36 patients who received 
8 mg ondansetron prior to SAB. No specific population of patients was identified, only that they 
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all received spinal anesthesia. No preloading of fluids was done prior to the procedure. In fact, 
each patient was limited to 200 ml sodium chloride during the study period. Each patient 
received oral midazolam (7.5 mg) one hour prior to anesthesia. Four ml bupivacaine 0.5% (20 
mg) was administered intrathecally to each patient. Hypotension was defined as SBP < 90 
mmHg. They determined a significant difference between groups in development of 
hypotension; 20% of patients in the control group versus 2.7% of patients in the intervention 
group developed hypotension (p.332-339).  
Owczuk et al. (2015) examined 53 patients all greater than 70 years of age. The control 
group had 27 patients and was compared to 26 patients in an intervention group which received 8 
mg ondansetron five minutes before SAB. Fluids were limited to 200 ml or less during the study 
period. Each patient was given 2.5 to 3 ml 0.5% bupivacaine (12.5 – 15 mg) intrathecally. 
Hypotension was defined as SBP < 90 mmHg, or a SBP decrease of > 20% baseline value. The 
authors determined that in the intervention group, SBP was significantly higher five minutes 
after the block was established, and that MAP and DBP were significantly higher at post-block 
intervals of 5, 10, and 15 minutes (p.598-607).  
Article Review Discussion 
There have been many studies looking at how intravenous ondansetron affects 
hemodynamics after the administration of spinal anesthesia. Unfortunately, there exists a large 
variation in how these studies were conducted. Perhaps the most noteworthy differences include 
amount and dose of local anesthetic used, adjunct medications used in the spinals, the use of 
colloid or crystalloid pre- or co-loading, definitions of hypotension, the threshold for treating 
blood pressure, patient populations and demographics, and dose of ondansetron used.  
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Of the 13 studies reviewed, eight determined that pre-treating with intravenous 
ondansetron did reduce the incidence of resultant hypotension. Five of the studies determined 
that the incidence of hypotension was the same between treatment and control groups. While not 
all the studies addressed the amount of vasopressor medications used, seven cited that patients 
who were pretreated with ondansetron required less. Only one cited that the vasopressor load 
was the same between study groups.  
An additional barrier in determining the true effectiveness of this intervention, is that 
there are many factors that could contribute to the development of hypotension (not exclusively 
sympathectomy from spinal anesthesia). Some of these factors include, but are not limited to, the 
administration of Pitocin, which can cause transient hypotension if rapidly infused, the use of 
propofol infusions, which inhibits sympathetic vasoconstrictor activity, and metabolic 
byproducts that may accumulate if a tourniquet is used (Butterworth, Mackey, & Wasnick, 
2013).  
Practice Recommendations 
There remains a need for additional, more uniform studies on this topic. Though likely it 
will be impossible to abolish all variations that exist between the studies, if some of the variables 
are eliminated, a more determinant conclusion could be reached on the effectiveness of this 
intervention. Until then, it does seem prudent to administer 4 mg ondansetron intravenously 
about five minutes prior to administering spinal anesthesia. The reasons for this conclusion 
include a lack of risk and adverse effects of this dose, the potential for decreasing hypotension, 
which does have negative consequences, and the likelihood of using a decreased amount of 
vasopressor medication, which is cost saving. Most of these patients will receive ondansetron 
during the procedure anyway, so there is no additional cost of this practice. It is important, 
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however, that each anesthesia practitioner uses case-to-case judgement. It should be realized that 
this practice cannot fully replace the current strategies of mitigating spinal-induced hypotension, 
but should rather be looked at as an additional strategy to be used in conjunction with the tools 
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